Treated eye (n=25) | Control eye (n=25) | p Value | |
Best corrected visual acuity (logMAR) | |||
Baseline | −0.05±0.07 | −0.06±0.07 | 0.54 |
Day 7 | −0.06±0.07 | −0.06±0.06 | 0.88 |
Day 14 | −0.07±0.06 | −0.07±0.06 | 0.92 |
p | 0.12 | 0.52 | |
Eyelid itching grade | |||
Baseline | 0 (0–0) | 0 (0–0) | >0.99 |
Day 7 | 0 (0–0) | 0 (0–0) | 0.55 |
Day 14 | 0 (0–0) | 0 (0–0) | 0.55 |
p | 0.82 | 0.38 | |
Eyelid pain grade | |||
Baseline | 0 (0–0) | 0 (0–0) | >0.99 |
Day 7 | 0 (0–0) | 0 (0–0) | 0.25 |
Day 14 | 0 (0–0) | 0 (0–0) | >0.99 |
p | 0.81 | 0.77 | |
Bulbar conjunctival hyperaemia score (out of 4) | |||
Baseline | 0.6±0.3 | 0.6±0.3 | 0.48 |
Day 7 | 0.6±0.3 | 0.6±0.3 | 0.19 |
Day 14 | 0.6±0.2 | 0.5±0.2 | 0.27 |
p | 0.18 | 0.68 | |
Palpebral erythema score (out of 4) | |||
Baseline | 0.3±0.3 | 0.3±0.3 | 0.60 |
Day 7 | 0.2±0.2 | 0.2±0.2 | 0.72 |
Day 14 | 0.2±0.2 | 0.2±0.2 | 0.97 |
p | 0.83 | 0.21 | |
Sodium fluorescein staining score (out of 55) | |||
Baseline | 2.3±2.1 | 2.4±2.3 | 0.96 |
Day 7 | 2.6±1.9 | 2.0±1.8 | 0.09 |
Day 14 | 2.0±1.8 | 1.8±1.6 | 0.83 |
p | 0.22 | 0.48 | |
Lissamine green staining score (out of 55) | |||
Baseline | 1.1±0.9 | 1.2±0.9 | 0.98 |
Day 7 | 0.9±0.8 | 1.0±0.8 | 0.99 |
Day 14 | 1.2±0.9 | 0.6±0.4 | 0.10 |
p | 0.51 | 0.21 | |
Lid wiper epitheliopathy grade | |||
Baseline | 0 (0–0) | 0 (0–0) | 0.91 |
Day 7 | 0 (0–0) | 0 (0–0) | 0.83 |
Day 14 | 0 (0–0) | 0 (0–0) | 0.20 |
p | 0.90 | 0.28 | |
Tear film lipid layer grade | |||
Baseline | 3 (2–4) | 3 (2–4) | 0.86 |
Day 7 | 3 (2–4) | 3 (2–4) | 0.98 |
Day 14 | 3 (2–5) | 3 (2–4) | 0.29 |
p | 0.71 | 0.21 | |
Tear evaporation rate (g/m2/h) | |||
Baseline | 60±35 | 54±27 | 0.22 |
Day 7 | 60±32 | 59±31 | 0.99 |
Day 14 | 47±24 | 46±25 | 0.98 |
p | 0.14 | 0.23 | |
Non-invasive tear film break-up time (s) | |||
Baseline | 11.9±8.1 | 13.7±10.8 | 0.73 |
Day 7 | 13.7±11.6 | 12.0±8.8 | 0.68 |
Day 14 | 14.3±11.5 | 12.7±9.0 | 0.86 |
p | 0.76 | 0.53 | |
Tear film osmolarity (mOsmol/L) | |||
Baseline | 301±12 | 307±21 | 0.28 |
Day 7 | 307±18 | 304±10 | 0.90 |
Day 14 | 303±19 | 303±17 | >0.99 |
p | 0.50 | 0.26 | |
Tear meniscus height (mm) | |||
Baseline | 0.26±0.13 | 0.27±0.12 | 0.78 |
Day 7 | 0.27±0.12 | 0.26±0.08 | 0.87 |
Day 14 | 0.27±0.12 | 0.25±0.08 | 0.49 |
p | 0.93 | 0.24 | |
MMP-9 expression | |||
Baseline | 6.54±13.53 | 13.42±42.23 | 0.37 |
Day 14 | 9.27±22.46 | 8.52±19.09 | 0.80 |
p | 0.93 | 0.58 | |
IL-6 expression | |||
Baseline | 5.18±6.94 | 2.91±4.16 | 0.85 |
Day 14 | 3.89±5.93 | 10.68±22.75 | 0.12 |
p | 0.89 | 0.11 | |
MUC5AC expression | |||
Baseline | 906.3±857.4 | 940.3±745.5 | 0.65 |
Day 14 | 725.7±738.3 | 1196.7±1455.2 | 0.43 |
p | 0.32 | 0.75 |
IL-6, interleukin-6; MMP-9, matrix metalloproteinase-9; MUC5AC, mucin-5AC.